Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 237
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
Tell the FDA What Psychedelic Care Should Look Like. You Have Until Monday.
When Psychedelic Experiences Turn into Crisis, Training Can Make All the Difference
Weekly Psychedelic Policy Briefing: September 30th, 2026
PTSF82 – Wonderland Miami, with Patrick Moher of Microdose
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy...
Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in...
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Open-label study of COMP360 psilocybin therapy for depression in cancer patients...
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine...
COMPASS Pathways is granted new US patent for crystalline psilocybin
atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness...
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in...
Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and...
Load more